752 related articles for article (PubMed ID: 14513166)
1. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
Cardoso F
Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
[TBL] [Abstract][Full Text] [Related]
2. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
Lang AM
Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
[TBL] [Abstract][Full Text] [Related]
3. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
Sankhla C; Jankovic J; Duane D
Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type B for cervical dystonia.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of botulinum toxin type A in treatment of different forms of focal dystonias in the Serbian population: experience of the Botulinum Toxin Outpatients Department.
Tomić A; Vujović B; Svetel M; Misković ND; Petrović I; Pekmezović T; Kostić VS
Vojnosanit Pregl; 2015 Dec; 72(12):1069-73. PubMed ID: 26898029
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms.
Wan XH; Vuong KD; Jankovic J
Chin Med Sci J; 2005 Mar; 20(1):44-7. PubMed ID: 15844312
[TBL] [Abstract][Full Text] [Related]
8. The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A -- initial experiences.
Barnes MP; Best D; Kidd L; Roberts B; Stark S; Weeks P; Whitaker J
Eur J Neurol; 2005 Dec; 12(12):947-55. PubMed ID: 16324088
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
10. Jaw-opening oromandibular dystonia secondary to Wilson's disease treated with botulinum toxin type A.
Teive HA; Klüppel LE; Munhoz RP; Becker N; Müller PR; Werneck LC
Arq Neuropsiquiatr; 2012 Jun; 70(6):407-9. PubMed ID: 22699536
[TBL] [Abstract][Full Text] [Related]
11. An open-label study of botulinum toxin A for treatment of tardive dystonia.
Tarsy D; Kaufman D; Sethi KD; Rivner MH; Molho E; Factor S
Clin Neuropharmacol; 1997 Feb; 20(1):90-3. PubMed ID: 9037579
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type B for cervical dystonia.
Marques RE; Duarte GS; Rodrigues FB; Castelão M; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004315. PubMed ID: 27176573
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
Duarte GS; Castelão M; Rodrigues FB; Marques RE; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004314. PubMed ID: 27782297
[TBL] [Abstract][Full Text] [Related]
14. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
15. Response and immunoresistance to botulinum toxin injections.
Jankovic J; Schwartz K
Neurology; 1995 Sep; 45(9):1743-6. PubMed ID: 7675238
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
17. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based medicine in botulinum toxin therapy for cervical dystonia.
Ceballos-Baumann AO
J Neurol; 2001 Apr; 248 Suppl 1():14-20. PubMed ID: 11357233
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
Tan EK; Jankovic J
Neurology; 1999 Dec; 53(9):2102-7. PubMed ID: 10599789
[TBL] [Abstract][Full Text] [Related]
20. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials.
Lew MF; Brashear A; Factor S
Neurology; 2000; 55(12 Suppl 5):S29-35. PubMed ID: 11188982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
